David Weinstock

33PUBLICATIONS
296CO-AUTHORS
Cellular immunologyMolecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Dec 05, 2025
Integrating single-cell biophysical and transcriptomic features to resolve functional heterogeneity in mantle cell lymphoma.

Ye Zhang, Lydie Debaize, Adam Langenbucher

|Jul 31, 2025
Combining MCL-1 inhibition and CD37-directed chimeric antigen receptor T cells as an effective strategy to target T-cell lymphoma.

Tayla B Heavican-Foral, Felix Korell, Irene Scarfò

|Jun 13, 2025
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma.

Alyssa Bouska, Weiwei Zhang, Sunandini Sharma

|Nov 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

|Oct 07, 2024
Asciminib plus dasatinib and prednisone for Philadelphia chromosome-positive acute leukemia.

Marlise R Luskin, Mark A Murakami, Julia Keating

|Jun 25, 2024
Mutation and cell state compatibility is required and targetable in Ph+ acute lymphoblastic leukemia minimal residual disease.

Peter S Winter, Michelle L Ramseier, Andrew W Navia

Pageof 6

Frequent Collaborators

4 joint publications

Ajit J Nirmal

4 joint publications

Ran Xu

3 joint publications

Raphael Koch

3 joint publications

Santosha Vardhana